portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Bristol Myers (BMY) Trading Near $28.12 Support Level
 
CreateTime:2011-08-19     Source:FBB-Seven Summits Research Editor:xujintao
Text Size:       
 

Bristol Myers (BMY.) closed Wednesday's seesaw trading session at $28.51. In the past year, the stock has hit a 52-week low of $24.97 and 52-week high of $29.73. Bristol Myers (RCODE:BMY:) stock has been showing support around $28.12 and resistance in the $28.92 range. Technical indicators for the stock are Bullish and S&P gives Bristol Myers (RCODE:BMY:) a neutral 3 STARS (out of 5) hold rating. For a hedged play on Bristol Myers (RCODE:BMY:), look at the Dec '11 $28.00 covered call for a net debit in the $26.88 area. That is also the break-even stock price for this trade. This covered call has a duration of 121 days, provides 5.72% downside protection and an assigned return rate of 4.17% for an annualized return rate of 12.57% (for comparison purposes only). A lower-cost hedged play for Bristol Myers (RCODE:BMY:) would use a longer term call option in place of the covered call stock purchase. To use this strategy look at going long the Bristol Myers (RCODE:BMY:) Jan '13 $20.00 call and selling the Dec '11 $28.00 call for a total debit of $7.02. The trade has a lifespan of 121 days and would provide 5.23% downside protection and an assigned return rate of 13.96% for an annualized return rate of 42% (for comparison purposes only). Bristol Myers (RCODE:BMY:) has a current annual dividend yield of 4.69%.


Related Reports
China Medical Robot Industry Report, 2020-2026
China Heparin Industry Report, 2015-2018
Global and China Stem Cell Industry Report, 2015-2018
China Medical Robot Industry Report, 2014-2018
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1